Company Search:
Advanced Search
Sponsored Links
Imugene Limited Company Snapshot
Imugene Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imugene Limited with three other companies in this sector in Australia: Adalta Ltd (2018 sales of 2.08 million Australian Dollars [US$1.51 million] ), Anatara Lifesciences Ltd (1.56 million Australian Dollars [US$1.14 million] ), and Medibio Ltd (2.60 million Australian Dollars [US$1.89 million] ).

Sales Analysis. Imugene Limited reported sales of A$1.94 million (US$1.41 million) for the fiscal year ending June of 2018. This represents an increase of 61.3% versus 2017, when the company's sales were A$1.20 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Imugene Limited
  Stock Performance Chart for Imugene Limited
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): .02
(Figures in Australian Dollars)
1 Week -4.3%   13 Weeks 10.0%  
4 Weeks -4.3%   52 Weeks 38.4%  
Imugene Limited Key Data:
  Ticker: IMU Country: Australia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,935,113
(Year Ending Jan 2019).
  Currency: Australian Dollars Market Cap: 62,807,412
  Fiscal Yr Ends: June Shares Outstanding: 2,854,882,382
  Share Type: Ordinary Closely Held Shares: 545,092,187
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.